About this series
Health care professionals are starting to realize the importance of managing neuropsychiatric complications in neurological disease, they disturb the process of care and are indicators of poor outcome, they also produce significant caregiver burden. This series will describe neuropsychiatric symptoms of major neurological diseases including new drugs (new anti-psychotics, mood stabilizers, antidepressants, cholinergic agents) that are available and other interventions for the management of these complications. This series will be targeted at neurologists, geriatricians, psychiatrists, internists, hospitalists, intensive care MDs, psychologists ad neuropsychologists, research and specialised nurses, clinical researchers and methodologists. Each volume will provide an up to date comprehensive review of the neuropsychiatry of major neurological diseases by active authorities in the field internationally. Emphasis will be placed on the diagnostic and management issues to serve as a standard reference book for clinicians of several specialities. Volumes will feature: - Critical appraisal of the methodological aspects and limitations of current research including ongoing controversies in the field. - Focus on the pharmacological aspects of management to provide robust information on drug dosages, side effects and interaction.